Hugo Vicente Miranda

Cited by

	All	Since 2019
Citations	2434	1689
h-index	22	18
i10-index	25	25

340

170

255

20072008200920102011201220132014201520162017201820192020202120222023202412 15 17 18 23 36 56 62 59 81 145 190 263 286 283 324 284 249

Public access

View all

18 articles

1 article

available

not available

Based on funding mandates

Co-authors

Tiago Fleming OuteiroUniversity Medical Center Goettingen, Goettingen, GermanyVerified email at gwdg.de
Luísa V. LopesPrincipal Investigator, iMM, Faculdade de Medicina, Universidade de LisboaVerified email at medicina.ulisboa.pt
Ana M SebastiaoFull Professor, Faculty of Medicine, Institute of Molecular Medicine, University of Lisbon, PortugalVerified email at fm.ul.pt
Eva M. SzegoDept. Neurology, Technische Universität DresdenVerified email at ukdd.de
Ricardo A GomesiBETVerified email at ibet.pt
Francisco J. EnguitaFaculdade de Medicina, Universidade de Lisboa, Lisboa, PortugalVerified email at medicina.ulisboa.pt
Miguel A. R. B. CastanhoBiochemistry, School of Medicine and Institute of Molecular Medicine, University of Lisbon, PortugalVerified email at medicina.ulisboa.pt
Hilal LashuelEPFLVerified email at epfl.ch
Luis Fonseca-OrnelasInstructor in Neurology Harvard Medical SchoolVerified email at bwh.harvard.edu
Jochen KluckenUniversity of Luxembourg, Centre Hospitalier du LuxembourgVerified email at uni.lu
Luís M. A. OliveiraSenior Associate Director, Michael J Fox Foundation for Parkinson's ResearchVerified email at michaeljfox.org
Henri G. FranquelimJunior Group Leader, Interfaculty Centre for Bioactive Matter, Leipzig University, GermanyVerified email at uni-leipzig.de
Sandra TenreiroNova Medical School- Universidade NOVA de Lisboa, Lisbon, PortugalVerified email at nms.unl.pt
Derek StewartJames Hutton instituteVerified email at hutton.ac.uk
Omar El-AgnafQatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar FoundationVerified email at hbku.edu.qa
Eero CastrénNeuroscience Center, University of Helsinki, FinlandVerified email at helsinki.fi
Nina N. KarpovaUniversity of HelsinkiVerified email at alumni.helsinki.fi
José RinoInstituto de Medicina MolecularVerified email at fm.ul.pt
Rodrigo CunhaUniversity of CoimbraVerified email at fmed.uc.pt
Isabel cordeiro santosC2TN, Sacavem or sacawem or bobadela, Instituto Superior TecnicoVerified email at ctn.tecnico.ulisboa.pt

Hugo Vicente Miranda

NOVA Medical School (NMS), New University of Lisbon (UNL)

Verified email at nms.unl.pt - Homepage

Neurosciences Dysmetabolism Parkinson's disease Glycation


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation MJ Diógenes, RB Dias, DM Rombo, H Vicente Miranda, F Maiolino, ... Journal of Neuroscience 32 (34), 11750-11762, 2012	304	2012
[alpha]-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B DG Ferreira, M Temido-Ferreira, H Vicente Miranda, VL Batalha, ... Nature Neuroscience, 2017	283	2017
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies H Vicente Miranda, ÉM Szegő, LMA Oliveira, C Breda, E Darendelioglu, ... Brain 140 (5), 1399-1419, 2017	217	2017
The sour side of neurodegenerative disorders: the effects of protein glycation H Vicente Miranda, TF Outeiro The Journal of pathology 221 (1), 13-25, 2010	195	2010
The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease RM de Oliveira, H Vicente Miranda, L Francelle, R Pinho, ÉM Szegö, ... PLoS biology 15 (3), e2000374, 2017	171	2017
Glycation in Parkinson's disease and Alzheimer's disease H Vicente Miranda, OMA El‐Agnaf, TF Outeiro Movement Disorders 31 (6), 782-790, 2016	161	2016
Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose AC Hoffmann, G Minakaki, S Menges, R Salvi, S Savitskiy, A Kazman, ... Scientific reports 9 (1), 544, 2019	142	2019
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease H Vicente Miranda, R Cássio, L Correia-Guedes, MA Gomes, A Chegão, ... Scientific Reports 7 (13713), 2017	105	2017
Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice S Kemppainen, T Rantamäki, A Jerónimo-Santos, G Lavasseur, H Autio, ... Neurobiology of aging 33 (6), 1122. e23-1122. e39, 2012	103	2012
Adenosine A2A receptors modulate α-synuclein aggregation and toxicity DG Ferreira, VL Batalha, H Vicente Miranda, JE Coelho, R Gomes, ... Cerebral Cortex, bhv268, 2015	102	2015
Yeast protein glycation in vivo by methylglyoxal RA Gomes, H Vicente Miranda, MS Silva, G Graça, AV Coelho, ... FEBS Journal 273 (23), 5273-5287, 2006	100	2006
(Poly) phenols protect from α-synuclein toxicity by reducing oxidative stress and promoting autophagy D Macedo, L Tavares, GJ McDougall, H Vicente Miranda, D Stewart, ... Human molecular genetics 24 (6), 1717-1732, 2015	79	2015
Protein glycation in Saccharomyces cerevisiae Argpyrimidine formation and methylglyoxal catabolism RA Gomes, M Sousa Silva, H Vicente Miranda, AEN Ferreira, ... The FEBS journal 272 (17), 4521-4531, 2005	70	2005
Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson’s disease A Koenig, H Vicente Miranda, TF Outeiro Journal of Parkinson's disease 8 (1), 33-43, 2018	61	2018
Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases L Sousa, M Guarda, MJ Meneses, MP Macedo, H Vicente Miranda The Journal of pathology 255 (4), 346-361, 2021	46	2021
Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes GR Morais, H Vicente Miranda, IC Santos, I Santos, TF Outeiro, A Paulo Bioorganic & medicinal chemistry 19 (24), 7698-7710, 2011	40	2011
Glycation potentiates neurodegeneration in models of Huntington’s disease H Vicente Miranda, MA Gomes, J Branco-Santos, C Breda, DF Lázaro, ... Scientific Reports 6, 2016	36	2016
Protein glycation and methylglyoxal metabolism in yeast: finding peptide needles in protein haystacks RA Gomes, H Vicente Miranda, M Sousa Silva, G Graça, AV Coelho, ... FEMS yeast research 8 (1), 174-181, 2008	32	2008
Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes A Chegão, M Guarda, BM Alexandre, L Shvachiy, M Temido-Ferreira, ... npj Parkinson's Disease 8 (1), 51, 2022	26	2022
Hsp27 reduces glycation‐induced toxicity and aggregation of alpha‐synuclein. TF Vicente Miranda, H., Chegão, A., Oliveira, M. S., Fernandes Gomes, B ... The FASEB Journal 34 (5), 6718-6728, 2020	26*	2020

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors